CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma
CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma
CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma
دوشنبه 7 آبان 1403